EAU 26 London 🇬🇧
Very happy to present our study of Endourology section of EAU and to reconnect to friends and colleagues from all around the world.
@D_Castellani@CarlottaNedbal@DocGauhar@steffiyuen
A big thank you to @D_Castellani , @DocGauhar , and @steffiyuen for their constant guidance and encouragement 💙. It’s all about teamwork!
And huge congratulations to Steffi for winning the Best Researcher Award 🏆 — so well deserved!
On to what comes next.
What an amazing Endourology family!
Proud to have presented our head-to-head comparison between suction Mini-PCNL and FANS at #ICE25 in Rome.
Really grateful for the support of friends from all over the world 🌍 and for all the new connections made.
Congratulations for the 1st Head-to-head comparison betwen # FANS and #SM-PCNL
✅SM-PCNL has higher 💯 % SFR
For more complex stones (Guys 2 & 3)
✅FANS has faster recovery and less PO pain
✅Both are SAFE and EFFECTIVE
Paving the way for SUCTION to become gold-standard for stone treatment and helping us to provide proper counseling for patients.
Take into consideration stone volume, complexity score (GSS) and patient preferences before choosing the surgical approach! ( Patient Stone Approach)
@DocGauhar@Urologeman@ytanidir
Rectal Swab–based Targeted Prophylactic Antibiotics Reduce Infectious Complications After Transrectal Prostate Biopsy
https://t.co/7k4oQUTqNi
In this systematic review and meta-analysis of nine randomized controlled trials including 3,002 patients, the use of targeted prophylactic antibiotics (TPAs) based on rectal swab cultures before transrectal ultrasound-guided prostate biopsy (TRUS-PB) was associated with a significant reduction in postbiopsy febrile urinary tract infections compared with empiric antibiotic prophylaxis (2.7% vs 5.2%; risk ratio 0.54, p = 0.003). The number needed to treat to prevent one febrile infection was 40. However, no significant difference was observed in the incidence of sepsis between the two groups.
These findings support incorporating rectal swab–guided antibiotic selection into prebiopsy protocols to reduce infection risk in patients undergoing TRUS-PB, though further research is warranted to clarify its impact on sepsis prevention. #ProstateCancer
Ichiro Tsuboi
@Mehdi_Kardoust@fazekasMD@miszczyk_marcin@A_Cormio@K_Tatsushi@kensuke_bekku@PiotrChlosta@Albert0Briganti@DrShariat@OncoAlert 🚨
@Silke_Gillessen@AOmlin@nataliagandur@bavilima
📊 PARPi show no clinically meaningful deterioration in health-related quality of life in mCRPC.
🔍 This meta-analysis underscores the critical need for nuanced interpretation of HRQoL data in the palliative setting.
👉🏼 https://t.co/TMBzFpOyrZ